Last week, Pershing Square exited its entire stake in General Growth Properties.
Flash memory card maker SanDisk was a 0.40% position in Appaloosa’s portfolio that the hedge fund exited last quarter.
Greenlight disclosed a 0.99% new position in Take-Two Interactive (TTWO), a developer, marketer, and publisher of interactive entertainment for consumers around the globe.
Ackman’s Pershing Square trimmed its holding in alcoholic-beverage maker Beam Inc.The hedge fund had now owns a 7.1% stake in Beam.
David Tepper’s Appaloosa exited a 0.49% position in Bank of America (BAC) last quarter.
Pershing Square has sold off most of its stake in Procter & Gamble the size of the position reduced to 739,605 last quarter.
Hertz Global Holdings (HTZ) was a 0.53% position that was eliminated last quarter by Appaloosa.
Greenlight disclosed a 1% new position in storage and data provider EMC Corp (EMC) in 4Q 2013. EMC’s 4Q results beat analyst expectations.
Canadian Pacific Railway is a position at 31.55 % in Pershing Square’s U.S. long portfolio.
Baidu (BIDU) is a 0.46% position in Appaloosa’s ~$7 billion U.S. long portfolio.
Since its inception in May 1996, Greenlight Capital has returned 2,211% cumulatively or 19.5% annualized, both net of fees and expenses.
Pershing Square increased its position in Air Products and Chemicals, Inc. from 21.31% in 3Q 2013 to 27.91% in 4Q 2013.
Eastman Chemical Company (EMN) is a 0.61% position initiated last quarter by Appaloosa.
Appaloosa Management initiated a 0.63% position in oilfield service company Halliburton (HAL) last quarter.
Bill Ackman’s Pershing Square increased position in Burger King Worldwide from 7.29% in 3Q 2013 to 10.66% in 4Q.
Soros Fund Management exited a 0.83% position in Constellation Brands (STZ) last quarter. Constellation closed the Grupo Modelo U.S. beer business acquisition in June 2013.
Appaloosa Management’s top new buy last quarter was American Airlines Group (AAL), with a 2.22% position in the hedge fund’s U.S. long portfolio.
Bill Ackman’s Pershing Square Capital Management did not initiate new stakes in 4Q 2013.
Soros sold its 1.20% position in Johnson & Johnson (JNJ) last quarter. Johnson & Johnson’s reported 37% increase in adjusted net earnings in 4Q was mainly driven by its pharmaceutical segment.
Appaloosa Management initiated new positions and sold some existing positions in 4Q 2013.